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CC BY-NC-ND license (http://creativBackground/Purpose: Gingival overgrowth occurs as a side effect of systemic medication with
immunosuppressant cyclosporine A (CsA). Slug, a master regulator of epithelialemesenchymal
transition, is dramatically upregulated in a variety of fibrotic diseases. The aim of this study is
to investigate the role of epithelialemesenchymal transition marker Slug in the pathogenesis
of CsA-induced gingival overgrowth.
Methods: Clinically healthy gingiva and CsA-induced gingival overgrowth specimens were
analyzed by immunohistochemistry. The effect of CsA on normal human gingival fibroblasts
(HGFs) was used to elucidate whether Slug expression could be affected by CsA by real-time
reverse transcription-polymerase chain reaction and western blot. Cell proliferation in CsA-
treated HGFs with Slug lentiviral-mediated shRNAi knockdown was evaluated by tetrazolium
bromide reduction assay.
Results: Slug expression was higher in CsA-induced gingival overgrowth specimens than in clin-
ical healthy gingiva (p < 0.05). Slug expression was significantly higher in CsA-induced gingival
overgrowth specimens with higher levels of inflammatory infiltrates (p < 0.05). CsA was found
to increase Slug transcript and protein expression in HGFs in a dose-dependent manner
(p < 0.05). In addition, knockdown of Slug significantly suppressed CsA-induced cell prolifera-
tion in HGFs (p < 0.05).have no conflicts of interest relevant to this article.
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Slug knockdown in CsA-treated HGFs 603Conclusion: Taken together, upregulation of Slug in HGFs stimulated by CsA may play an impor-
tant role in the pathogenesis of CsA-induced gingival overgrowth.
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Gingival overgrowth is a common side effect of the chronic
use of immunosuppressive drug cyclosporine A (CsA). Etio-
logical factors causing and underlying gingival overgrowth
have been reviewed, and it was determined that local,
systemic, and genetic factors may also contribute to its
development and progression.1 Histological change of
gingival overgrowth is characterized by fibrotic or expanded
connective tissues as well as by an enlarged gingival
epithelium with different degrees of inflammation.2 CsA-
induced gingival overgrowth may result in dysregulation of
connective tissue hemostasis, which interferes with fibro-
blast proliferation3 with an increased accumulation of
extracellular matrix.4e10 However, pathologic mechanisms
of CsA-induced gingival overgrowth still need to be further
clarified.
Epithelialemesenchymal transition (EMT), a trans-
differentiation program that converts adherent epithelial
cells into individual migratory cells, is involved in embry-
onic development and disease development including drug-
induced gingival overgrowth.11,12 Slug is a well-
characterized member of the Snail superfamily, and
human Slug has been demonstrated recently, which func-
tions as a transcriptional repressor by specifically binding to
the E-box motif. Slug is a key regulator of the EMT of
mesodermal cells.13 Several experimental and clinical
studies have revealed that overexpression of Slug leads to a
loss of E-cadherin expression and has also been implicated
in pathological alterations of the epithelial-to-
mesenchymal cell phenotype. Recently, Slug has been
found to be overexpressed in keloid14 and Crohn’s disease-
associated intestinal fibrosis.15 However, Slug-mediated
molecular mechanisms in CsA-induced gingival overgrowth
still remains to be elucidated.
Recently, chlorhexidine mouthwash16 and epi-
gallocatechin-3-gallate17 were found to be the adjuvants for
the amelioration or prevention of CsA-induced gingival
overgrowth. In this study,we explore a possible role of Slug in
the pathogenesis of CsA-induced gingival overgrowth. Slug
expression was demonstrated to play a major role in the
pathogenesis of CsA-induced gingival overgrowth. In addi-
tion, Slug may serve as a new therapeutic target for the
treatment of CsA-induced gingival overgrowth in the future.Methods
Immunohistochemistry
Following approval by the Institutional Review Board of the
Chung Shan Medical University Hospital, Taichung, Taiwan,surgically removed gingival tissues were fixed with 10%
buffered formalin overnight; the specimens were dehy-
drated in an ascending series of graded alcohols and
embedded in paraffin. Sections (5 mm) were stained with
the monoclonal anti-Slug antibody (sc-15391; Santa Cruz
Biotechnology, Santa Cruz, CA, USA; 1:100 dilution) using a
standard avidinebiotineperoxidase complex method. The
compound 3-amino-9-ethylcarbazole (DAKO, Carpinteria,
CA, USA) was then used as the substrate for localizing
antibody binding. Negative controls included serial sections
from which either primary or secondary antibodies were
excluded. The preparations were counterstained with he-
matoxylin, mounted with Permount (Merck, Darmstadt,
Germany), and examined by light microscopy. In addition,
one section from each CsA-induced gingival overgrowth
specimen was stained with hematoxylin and eosin to eval-
uate the magnitude of inflammation at the histological
level, as described previously.5,6Cell cultures
Five healthy individuals were selected from the crown
lengthening procedure for this study. HGFs were cultured
using an explant technique, as described previously.4,8Slug expression analysis
HGFs were arrested in G0 by serum deprivation according to
our previous experiments.7 Nearly confluent monolayers of
HGFs were washed with a serum-free medium and imme-
diately thereafter exposed, at indicated incubation times,
to 0 ng/mL, 100 ng/mL, 200 ng/mL, 500 ng/mL, and
1000 ng/mL CsA (Sigma-Aldrich, St Louis, MO, USA). Cell
lysates were collected at 48 hours for real-time reverse
transcription-polymerase chain reaction (RT-PCR) and
western blot assays. Cultures without fetal calf serum (FCS)
were used as negative control.Real-time RT-PCR
Total RNA of cells was purified using Trizol reagent (Invi-
trogen Life Technologies, Carlsbad, CA, USA) according to
our previous publication.12 The following Slug primers
(NM_003068) were designed: forward: GTGAT-
TATTTCCCCGTATCTCTAT; reverse: CAATGGCATGGGGGTCT-
GAAAG. The glyceraldehyde-3-phosphate dehydrogenase
(GAPDH ) housekeeping gene was amplified as a reference
standard. The following GAPDH primers (NM_002046) were
designed: GAPDH (forward): CATCATCCCTGCCTCTACTG;
GAPDH (reverse): GCCTGCTTCACCACCTTC.
Table 1 Localization and number of cells expressing Slug
in four clinical healthy gingival specimens and 13 cyclo-
sporine A-induced gingival overgrowth specimens.
Epithelial
cells
Fibroblasts Inflammatory
cells
Clinical healthy
gingival specimens
1 (25) 1 (25) 0 (0%)
CsA-induced gingival
overgrowth
specimens
4 (30.8) 11 (84.6) 13 (100)
Data are presented as n (%).
CsA Z cyclosporine A.
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Extraction of proteins from cells and immunoblotting
analysis were performed as described previously.8,9
Slug knockdown in CsA-treated HGFs by lentiviral-
mediated shRNAi
The pLV-RNAi vector was purchased from Biosettia Inc. (San
Diego, CA, USA). The method of cloning the double-stranded
shRNA sequence is described according to our recent publi-
cation.12 Lentiviral vectors expressing short hairpin RNA
(shRNA) that targets human Slug (sh-Slug-1: 50-AAAAGC-
ATACCACAAATGCAATATTGGATCCAATATTGCATTTGTGGTAT-
GC-30; sh-Slug-2: 50-AAAAGCCCAGTCTAGAAAATCTTTTGGA-
TCCAAAAGATTTTCTAGACTGGGC-30) were synthesized and
cloned into pLVRNAi to generate a lentiviral expression vec-
tor. The shRNA that targets luciferase (sh-Luc: 50-
CCGGACTTACGCTGAGTACTTCGAACTCGAGTTCGAAGTACT-
CAGCGTA-30) was utilized for an experimental control.
Cell proliferation
HGFs placed in 96-well plates were washed with phosphate-
buffered saline, and the medium was replaced with
Dulbecco’s modified Eagle’s medium (DMEM) for serum
starvation overnight. After treatment with 200 ng/mL CsA
for 48 hours, cell proliferation was tested using the MTT [3-
(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bro-
mide] assay kit (Sigma-Aldrich) as described previously.12
Statistical analysis
Three replicates of each experiment were performed for
each test. All assays were repeated three times to ensure
reproducibility. The correlation between Slug expression
and the grade of inflammation in CsA-induced gingival
overgrowth specimens was analyzed using Fisher’s exact
test. The significance of the results obtained from control
and CsA-treated HGFs was statistically analyzed by one-way
analysis of variance. Differences between the treatments
were analyzed by Duncan’s test. A p value < 0.05 was
considered to be statistically significant.Figure 1 (A) Very faint immunoreactivity of Slug is observed in n
for Slug is noted in the CsA-induced gingival overgrowth specimenResults
Slug staining in gingival tissue was stronger in the CsA-
induced gingival overgrowth group than in the clinical
healthy gingival group (p < 0.05). Figure 1A represents
gingival tissue obtained from the clinical healthy gingival
group with faint Slug expression. In the CsA-induced
gingival overgrowth group, Slug expression was observed
mainly in the cytoplasm of fibroblasts, epithelial cells, and
inflammatory cells (Figure 1B).
As shown in Table 1, rank orders of cells positively
stained by Slug in the CsA-induced gingival overgrowth
group were as follows: inflammatory cells
(100%) > fibroblasts (84.6%) > epithelial cells (30.8%). Slug
positive staining in the clinical healthy gingival group was
occasionally seen in fibroblasts and epithelial cells (Table
1). No expression of Slug was detected in the negative
control gingival specimens.
Slug expression in CsA-induced gingival overgrowth
specimens with low or high levels of inflammation is listed
in Table 2. A significantly greater Slug expression was noted
in CsA-induced gingival overgrowth tissues with high levels
of inflammation, as analyzed using Fisher’s exact test
(p Z 0.038).
HGFs were treated with CsA, and the levels of Slug
transcript and protein were measured by RT-PCR and
western blot. As shown in Figure 2, CsA was found to in-
crease Slug transcript in HGFs in a dose-dependent mannerormal human gingival tissue (200). (B) Strong immunostaining
(200). CsA Z cyclosporine A.
Table 2 Results of Slug expression and the grade of
inflammation in CsA-induced gingival overgrowth tissues.a
Inflammation high Inflammation low
Slug high 10 0
Slug low 1 2
CsA Z cyclosporine A.
a A significantly greater Slug expression was noted in CsA-
induced gingival overgrowth tissues with high levels of inflam-
mation as compared with tissues with low levels of inflamma-
tory cell infiltrates by Fisher’s exact test (p Z 0.038).
Figure 2 Slug mRNA expression is examined by RT-PCR. HGFs
were exposed for 48 hours in a medium containing various
concentrations of CsA as indicated. The relative Slug mRNA
expression represents the mean  SD. * Significant difference
from control values with p < 0.05. CsA Z cyclosporine A;
HGF Z human gingival fibroblast; RT-PCR Z reverse
transcription-polymerase chain reaction; SD Z standard
deviation.
Figure 3 CsA dose dependently induced Slug expression in HG
concentrations of CsA for a further 48 hours in a serum-free medium
was used as a protein loading control. (B) Protein levels of Slug stim
relative level of Slug protein expression was normalized against b-ac
represent the mean  SD. * Significant difference from control valu
fibroblast; SD Z standard deviation.
Slug knockdown in CsA-treated HGFs 605(p < 0.05). In addition, CsA was found to upregulate Slug
protein expression in a dose-dependent manner (p < 0.05;
Figure 3A). Using the AlphaImager 2000 (Alpha Innotech
Corp., San Leandro, CA, USA), the levels of the Slug protein
were found to increase about 1.6-, 3.2-, 3.0-, and 2.8-fold
after exposure to 100 ng/mL, 200 ng/mL, 500 ng/mL, and
1000 ng/mL CsA, respectively (Figure 3B).
To investigate the role of Slug in CsA-induced gingival
overgrowth, downregulation of Slug in CsA-treated HGFs
was achieved by viral transduction with the lentiviral vector
expressing shRNA targeting Slug. In addition, the lentiviral
vector expressing sh-Luc was used as a control. RT-PCR and
western blot were used to confirm the downregulation of
Slug expression by its shRNA. RT-PCR demonstrated that
lentivirus expressing both sh-Slug-1 and sh-Slug-2 markedly
reduced the level of CsA-induced Slug expression in HGFs
(Figure 4A). Western blot also demonstrated that the
knockdown of Slug could reduce Slug expression in CsA-
stimulated HGFs (Figure 4B).
In functional assays, we constructed lentivirus vector
with Slug shRNA and infected HGFs. As shown in Figure 5,
MTT results showed that Slug knockdown significantly
reduced cell proliferation of HGFs stimulated with 200 ng/
mL CsA (p < 0.05).
Discussion
Previously, it was reported that EMT likely occurs in drug-
induced gingival overgrowth including being induced by CsA
with diminished E-cadherin and elevated levels of FSP-1
and fibronectin.11 Slug is a transcriptional repressor of E-
cadherin, and its upregulation occurs in EMT. In this study,
to the best of our knowledge, we first found that Slug
expression is upregulated in CsA-induced gingival over-
growth specimens compared with clinical healthy gingival
tissues. Slug was detected in fibroblasts, epithelial cells,
and inflammatory cells. Taken together, our results suggest
that EMT is a biological process that may contribute to CsA-
induced gingival overgrowth via the Slug pathway.Fs. (A) HGFs were serum starved and treated with indicated
. The expression of Slug was detected by western blot; b-actin
ulated by CsA in HGFs were measured with a densitometer. The
tin signal, and the control was set as 1.0. Optical density values
es with p < 0.05. CsAZ cyclosporine A; HGFZ human gingival
Figure 4 The silencing effect of Slug shRNA in CsA-treated HGFs was validated transcriptionally by RT-PCR and western blot.
Single-cell suspension of HGFs was transduced with sh-Luc or sh-Slug lentivirus, individually or concurrently, and treated with or
without CsA (200 ng/mL) as indicated. (A) Result of RT-PCR. The relative Slug mRNA expression represents the mean  SD. (B)
Western blotting also demonstrated that knockdown of Slug significantly reduced Slug expression in CsA-stimulated HGFs. GAPDH
was used as a protein loading control. *p < 0.05, sh-Luc þ CsA group versus control group. **p < 0.05, sh-Slug-1þ CsA or sh-Slug-
2þ CsA versus sh-Luc þ CsA group. CsA Z cyclosporine A; GAPDH Z glyceraldehyde-3-phosphate dehydrogenase; HGF Z human
gingival fibroblast; RT-PCR Z reverse transcription-polymerase chain reaction; SD Z standard deviation.
Figure 5 Silencing of Slug expression suppresses 200 ng/mL CsA-stimulated cell proliferation capabilities of HGFs. Cell viability of
the control or Slug-knockdown CsA-treated HGFs was evaluated by an MTT assay. Cells were exposed for 48 hours in a medium
containing various concentrations of CsA as indicated. *p < 0.05, sh-Luc þ CsA group versus control group. **p < 0.05, sh-Slug-
1 þ CsA or sh-Slug-2 þ CsA versus sh-Luc þ CsA group. CsA Z cyclosporine A; HGF Z human gingival fibroblast; MTT Z 3-(4,5-
dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide.
606 C.-H. Tsai et al.In this study, the expression of Slug was also shown to
increase with the grade of inflammation in CsA-induced
gingival overgrowth specimens. The reason for this finding
is not clear. It has been reported that bacterial plaque and
the resulting gingival inflammation are factors that pro-
mote gingival overgrowth significantly.18 Inflammatory
mediators are believed to contribute to the pathogenesis of
periodontal diseases. Tumor necrosis factor-a was found to
upregulate Slug protein expression in human breast carci-
noma cell line MCF-7 cells.19 Recently, interleukin-1b wasalso shown to increase Slug expression in human oral
squamous cell carcinoma cell line TW2.6 cells.20 Therefore,
inflammatory cytokines secreted by infiltrated inflamma-
tory cells and fibroblasts might provide an inflammatory
microenvironment to promote EMT in the pathogenesis of
CsA-induced gingival overgrowth.
Transforming growth factor-b1 (TGF-b1) is a key regu-
lator of the biochemical mechanisms associated with the
pathogenesis of CsA-induced gingival overgrowth.21 The
Snail family of transcriptional repressors (Snail and Slug) is
Slug knockdown in CsA-treated HGFs 607a key downstream target of TGF-b1 that regulates tran-
scriptional E-cadherin repression.22 In addition, Slug mRNA
and protein levels were found to be significantly upregu-
lated by TGF-b1 in primary human gingival epithelial
cells.11 Therefore, the CsA-induced Slug mRNA and protein
expression in this study could be the effects of CsA-induced
TGF-b1 expression. Therefore, the interaction between
TGF-b1 and Slug is worthy of further investigation.
Fibroblasts are the principal cell type residing in con-
nective tissue and are the cells responsible for the forma-
tion and turnover of the extracellular matrix. Fibroblast
function is, in turn, regulated by bioactive molecules acting
in local tissue environment. To the best of our knowledge,
this study was the first to report that CsA upregulated Slug
mRNA and protein expression in HGFs. In addition, RT-PCR
and western blot confirmed that lentivirus expressing both
sh-Slug-1 and sh-Slug-2 markedly reduced the expression
level of CsA-induced Slug transcript and protein expression
in HGFs. Previously, CsA was found to increase the
expression of Slug protein in human choriocarcinoma cell
line JEG-3 cells.23 CsA was also found to increase Slug gene
and protein expression in human HK2 renal tubular cells.24
Taken together, induction of Slug expression by CsA is not
cell type specific. These findings suggest that one of the
pathogenic mechanisms of CsA-induced gingival overgrowth
may be the induction of Slug expression by resident cells in
response to CsA challenge.
Increased fibroblast proliferation by CsA in HGFs has
been characterized by the development and progression of
CsA-induced gingival overgrowth.21 In this study, knock-
down of Slug was first found to suppress CsA-stimulated cell
proliferation ability in HGFs. Similar results were reported
in the nonsmall cell lung cancer cell line A549 that knock-
down of Slug expression could suppress lung cancer cell
proliferation.25 Furthermore, the present in vitro findings
suggest that the downregulation of Slug may represent a
novel targeted therapy for potential antifibrosis in CsA-
induced gingival overgrowth.
In conclusion, to our knowledge, this is the first sys-
tematic attempt to evaluate the role of Slug expression in
CsA-induced gingival overgrowth in humans both in vivo and
in vitro. We have demonstrated that Slug is elevated in CsA-
induced gingival overgrowth compared with clinical healthy
gingival tissues. Data from our in vitro experiments showed
that CsA was capable of stimulating Slug mRNA and protein
expression in HGFs. Knockdown of Slug expression signifi-
cantly suppressed HGFs cell proliferation. The down-
regulation of Slug may represent a novel targeted therapy
for CsA-induced gingival overgrowth.Acknowledgments
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